cremophor

Known as: chremofore 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1973-2017
010203019732017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
Genexol-PM is a novel Cremophor EL-free polymeric micelle formulation of paclitaxel. This single arm, multicenter phase II study… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2006
Highly Cited
2006
ABI-007, an albumin-bound, 130-nm particle form of paclitaxel, was developed to avoid Cremophor/ethanol-associated toxicities in… (More)
  • figure 1
  • table 2
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2005
Highly Cited
2005
PURPOSE To compare the preclinical and clinical pharmacokinetic properties of paclitaxel formulated as a Cremophor-free, albumin… (More)
  • figure 2
  • figure 1
  • table 2
  • figure 3
  • table 3
Is this relevant?
Highly Cited
2004
Highly Cited
2004
PURPOSE The rationale for developing an alternative paclitaxel formulation concerns Cremophor EL-related side effects, and a… (More)
  • table 2
  • table 1
  • table 3
  • table 4
  • table 5
Is this relevant?
Highly Cited
2002
Highly Cited
2002
PURPOSE ABI-007 is a novel Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel. The absence of Cremophor… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
Highly Cited
2002
Highly Cited
2002
The objectives of this study were (1) to investigate the transporter inhibition activity of three nonionic surfactants on P… (More)
Is this relevant?
1999
1999
Purpose: We have previously shown that paclitaxel, when dissolved in water and instilled into the bladder, readily penetrates the… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
1998
Highly Cited
1998
BACKGROUND Cancer patients treated with the anticancer drug, paclitaxel (Taxol) often experience mild to severe hypersensitivity… (More)
Is this relevant?
1996
1996
The effect of the paclitaxel vehicle Cremophor on the pharmacokinetics of doxorubicin and doxorubicinol was studied in two groups… (More)
  • figure 1
  • table I
Is this relevant?
Highly Cited
1987
Highly Cited
1987
Taxol, selected for clinical trial because of its animal antitumor activity and unique structure and mechanism of action, was… (More)
  • table I
  • table 2
  • table 3
  • table 5
  • figure 2
Is this relevant?